Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Akeso to Share Global Strategy for New Drug Development at the 43rd J.P. Morgan Healthcare Conference 2025-01-07 11:18
The Registrational Clinical Data of Glecirasib was Published in Nature Medicine 2025-01-07 08:30
Technoderma Medicines Completes Positive Ph2a Proof- of Concept Trial with Topical TDM-180935 Ointment for Atopic Dermatitis 2025-01-06 21:00
I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program 2025-01-06 20:00
Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections Treatment under Expanded Access Investigational New Drug Program 2025-01-06 18:05
Chime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Atopic Dermatitis and Asthma Therapies Antibody Drug MG-K10 Late-Stage Clinical Trials and Commercialization 2025-01-03 21:15
GRIT Bio Appoints Jie Jia, Ph.D., as Chief Operating Officer 2025-01-03 15:30
Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene 2025-01-03 13:30
Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044 2025-01-03 01:43
Fapon Biopharma Introduces FP008 at Biotech Showcase: A Safer and More Effective Immunotherapy for Refractory Cancers 2025-01-02 17:17
FDA Grants Orphan Drug Designation to MicuRx's MRX-5 for NTM Infections 2025-01-02 12:52
Ractigen Therapeutics Founder Dr. Long-Cheng Li Awarded 2024 Life Science Ice Breaking Award 2024-12-31 20:00
Duality Biologics Announces B7H4 ADC Milestone Achievement and License Exercise by BeiGene 2024-12-31 08:00
I Peace manufactures 100 lines of GMP iPS Cells cumulatively 2024-12-31 04:24
Bridge Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference 2024-12-30 23:00
CARsgen Announces Positive Topline Results from China GC/GEJ Pivotal Phase II Clinical Trial of Claudin18.2 CAR-T (Satri-cel) 2024-12-30 21:50
Huadong Medicine Co., Ltd. and SynerK reached a strategic cooperation to jointly develop a novel siRNA drug SNK-2726 2024-12-30 13:00
Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design 2024-12-26 11:07
Haikou delivers mix of tradition and cutting-edge industry 2024-12-26 10:07
Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting 2024-12-25 15:42
1 2 3 4 5 170